Telomere shortening has been documented in the blood cells of recipients of allogeneic bone marrow transplants compared with their donors. Allogeneic peripheral blood progenitor cells (PBPCs) have been increasingly used as an alternative to bone marrow. Their advantages include earlier engraftment and immune reconstitution following transplantation. We have measured telomere length of neutrophils and T cells in fully engrafted recipients of allogeneic bone marrow (n = 19) and allogeneic PBPC (n = 17) and also measured sequential telomere length in four patients after transplantation. Overall, significant telomere shortening occurred in recipients in neutrophils (0.3 kb, P Ͻ 0.001) and T cells (0.2 kb, P = 0.045). The data demonstrate that first, the degree of shortening was the same for BM and PBPC transplants and was not related to the time taken to engraft neutrophils and platelets and second, telomere shortening occurs in the first year post transplant without further shortening during the period of observation. These data suggest that the superiority of engraftment seen in PBPC transplants is independent of telomere shortening and other mechanisms such as homing or seeding may be more important. Bone Marrow Transplantation (2001) 27, 1283-1286.
ised allogeneic PBPC transplantation. PBPC transplants result in earlier neutrophil and platelet recovery 6, 7 and more rapid immune reconstitution 8 compared to BM transplants. This may be attributed to the higher numbers of progenitor cells that are present in PBPC harvests 9, 10 or the biological differences that exist between progenitor cells derived from these two sources. PBPCs have a higher proportion of circulating progenitors in the G 0 /G 1 phase of the cell cycle, 11 a high content of clonogenic progenitor cells 12 and an altered adhesion molecule profile compared to BM. This may result in improved homing and seeding into the bone marrow. [13] [14] [15] The increased availability of progenitor cells for engraftment may, at least in part, abrogate the initial replicative stress following transplantation. We aimed to define whether patients receiving PBPC transplants as compared to BM transplants have a different degree of telomere shortening, which may be a reflection of haemopoietic stress post transplant. This may have a bearing on the choice of stem cells for allogeneic transplantation.
Patients and methods
Local Ethical Committee approval was obtained prior to commencement of this study. Samples of peripheral blood were obtained from 36 patients who had previously undergone either allogeneic BM transplantation (n = 19) or allogeneic PBPC transplantation (n = 17). All recipients were demonstrated to have 100% donor chimerism using variable tandem nucleotide repeat (VNTR) analysis or cytogenetic (X:Y) analysis. Concurrent control samples were obtained from their healthy donors in the majority of cases. In seven cases, donor blood was obtained some months prior to recipient blood. In these cases, the measured telomere length of the donor blood was adjusted to take into account normal telomere shortening with ageing.
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Patient characteristics
Nineteen BM donor/recipient pairs were compared with 17 PBPC pairs. The results are summarised in Table 1 . BM transplant patients received a median of 3.05 × 10 8 mono- 19, 20 it is apparent that the recipients of BM and PBPC transplants received similar CD34 + doses.
Neutrophil and T cell preparations
Neutrophils and T cells were obtained from whole blood as previously described. 18 Neutrophils were obtained from all 36 donor/recipient pairs but sufficient T cells for telomere analysis were available for only 50 individuals. Where comparative analyses were undertaken, only samples with paired neutrophil and T cell data were included.
Terminal restriction fragment (TRF) analysis
This was carried out using in-gel hybridisation as previously described. 18 
Statistical analysis
The data were parametric. Student's t-test and Levine's test for the equality of variances were used to assess the significance of observed differences. Regression analysis and Spearman's correlation coefficient were used to define any association between the extent of TRF shortening post transplant and clinical variables.
Results and discussion
This study is the first to compare telomere (TRF) shortening following allogeneic BMT and PBPC transplantation and the first to prospectively document changes in TRF length over a period of time in the same patient. When all transplants were analysed together, significant TRF shortening was observed in neutrophils (0.3 kb, P Ͻ 0.001) and T cells (0.2 kb, P = 0.045). Figure 1 shows the TRF shortening in neutrophils and T cells following both types of transplant by comparison of the mean donor TRF length with recipient TRF length. In addition, a direct analysis of individual paired samples was carried out. By this method, TRF shortening was observed in neutrophils (321 ± 90 base pairs (bp) for BMT recipients (n = 19, P = 0.002) and 296 ± 127 bp for PBPCT recipients (n = 17, P = 0.03)). Although there was telomere shortening in T cells of recipients compared to their donors this was statistically significant following BMT but not following PBSCT (289 ± 133 bp for bone marrow recipients (n = 15, P = 0.03) and 113 ± 379 bp (n = 9, P = NS) for PBPCT recipients) (Figure 1 ). The nonsignificance of the TRF shortening in T cells post PBPCT may be due to the small T cell sample number in the PBPC group (n = 9); alternatively it may suggest that the larger T cell dose associated with PBPC transplantation 8 results in a reduction in T cell proliferative stress. Insufficient T cell numbers precluded further analysis of telomere shortening in T cell sub-populations following transplantation, but it is possible that the observed T cell telomere shortening overall may partly reflect differences in these. It has been shown, for example, that transplant recipients have low percentages of naive CD4
+ and CD8 + T cells compared with normal adults. 21 Such cells, with the phenotype CD45RA + RO − , have been observed to have longer telomeres and to undergo telomere shortening during proliferation at a slower rate than memory T cells. 22 There was no statistically significant difference between BMT and PBPCT in terms of the amount of observed TRF shortening. Assuming a rate of shortening of 20-40 base pairs per year in the healthy general population, 17,18 the post-transplant shortening is the equivalent of approximately 7.5-15 years ageing for neutrophils and 5-10 years ageing for T cells. In order to compare TRF shortening between neutrophils and T cells, a direct analysis of individual paired samples was carried out only in those pairs where both neutrophil and T cell results were available for donor and recipient. The degree of shortening was equivalent for neutrophils and T cells.
The extent of TRF shortening was not associated with donor age, recipient age or donor telomere length. It was observed that T cells had significantly longer TRFs than neutrophils in both donors (n = 25, mean difference 311 ± 82 bp, P = 0.001) and transplant recipients (n = 25, mean difference 447 ± 99 bp, P Ͻ 0.001) (Figure 1 ), in agreement with previous studies. studied, G-CSF mobilisation has limited impact on telomere length, which has important implications for the counseling of potential PBPC cell donors. Accelerated telomere shortening occurred in the first year following transplantation. In 10 patients whose TRF length was assessed in the first year post transplant, the mean TRF shortening from the time of the transplant was 537 ± 155 bp compared to a mean TRF shortening of 221 ± 81 bp in 26 patients assessed between 1 and 13.3 years after the procedure. In four patients, an initial TRF measurement was made from the donor at the time of apheresis or bone marrow harvest, followed by sequential TRF assessments in the recipient over a 2 year period (Figure 2 ). There was evidence of significant telomere shortening within the first year of the transplant (P = 0.01) but thereafter there was no additional telomere loss. These observations are in keeping with studies in Safari cats undergoing autologous transplantation using glucose-6-phosphate dehydrogenase isoenzymes to track haemopoiesis. 23 Two phases of repopulating stem cell kinetics were described: initially there were significant fluctuations in the contributions of stem cell clones followed by more stable haemopoiesis. These may be mirrored by the two phases of telomere shortening, the more rapid early shortening suggesting extensive proliferation of engrafted stem and progenitor cells. Subsequent stabilisation in telomere shortening is likely to be the result of the establishment of steady-state haemopoiesis.
In agreement with previous studies, 6, 7, 24 transplantation of allogeneic peripheral blood progenitor cells resulted in more rapid platelet and neutrophil recovery although the difference was only statistically significant for platelet recovery to Ͼ20 × 10 9 /l (P = 0.05) and Ͼ50 × 10 9 /l (P = 0.04) ( Table 1 ). In our study, the numbers of CD34 qualitative differences in the progenitor cells transplanted are more likely to explain differences in engraftment. These qualitative differences do not, however abrogate the rapid telomere shortening described here for PBPC and BMT recipients. There was no correlation between the time taken to engraftment of neutrophils or platelets and the extent of TRF shortening. Furthermore, we found no correlation between the dose of MNCs and TRF shortening in BMT recipients (within the range 1.44-3.9 × 10 9 /kg) or between the CD34 + cell dose and TRF shortening in PBPCT recipients (within the range 1.58-7.04 × 10 6 /kg). This latter observation has been controversial with one study 1 demonstrating a correlation between stem cell dose and telomere shortening and others showing no such relationship. Our data suggest that stem cell usage after transplantation of adequate numbers of cells occurs independently of cell dose and is similar for both G-CSF-mobilised PBPCs and unmanipulated bone marrow cells. This implies that engraftment post transplant must initially occur from a limited stem cell pool which accounts for the rapid fall in telomere length described within the first year of transplantation.
An understanding of the mechanisms by which stem cells contribute to stable haemopoiesis post transplant is important for the development of gene therapy protocols. Future studies must concentrate on defining more accurately the stem and progenitor cell populations bearing this stress and the processes that influence stem cell usage post transplant.
